ES8505541A1 - Procedimiento para producir una preparacion de gel o preparacion que contiene gel - Google Patents

Procedimiento para producir una preparacion de gel o preparacion que contiene gel

Info

Publication number
ES8505541A1
ES8505541A1 ES535914A ES535914A ES8505541A1 ES 8505541 A1 ES8505541 A1 ES 8505541A1 ES 535914 A ES535914 A ES 535914A ES 535914 A ES535914 A ES 535914A ES 8505541 A1 ES8505541 A1 ES 8505541A1
Authority
ES
Spain
Prior art keywords
preparation
nitroester
disperse silica
finely disperse
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES535914A
Other languages
English (en)
Spanish (es)
Other versions
ES535914A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dynamit Nobel AG
Original Assignee
Dynamit Nobel AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dynamit Nobel AG filed Critical Dynamit Nobel AG
Publication of ES535914A0 publication Critical patent/ES535914A0/es
Publication of ES8505541A1 publication Critical patent/ES8505541A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES535914A 1983-09-17 1984-09-14 Procedimiento para producir una preparacion de gel o preparacion que contiene gel Expired ES8505541A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833333639 DE3333639A1 (de) 1983-09-17 1983-09-17 Zubereitung von nitroestern fuer die koronartherapie

Publications (2)

Publication Number Publication Date
ES535914A0 ES535914A0 (es) 1985-06-01
ES8505541A1 true ES8505541A1 (es) 1985-06-01

Family

ID=6209363

Family Applications (1)

Application Number Title Priority Date Filing Date
ES535914A Expired ES8505541A1 (es) 1983-09-17 1984-09-14 Procedimiento para producir una preparacion de gel o preparacion que contiene gel

Country Status (7)

Country Link
US (1) US4611008A (enExample)
EP (1) EP0137978B1 (enExample)
JP (1) JPH0645537B2 (enExample)
AT (1) ATE74518T1 (enExample)
DE (2) DE3333639A1 (enExample)
ES (1) ES8505541A1 (enExample)
FI (1) FI83838C (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63222113A (ja) * 1987-03-11 1988-09-16 Kao Corp 貼付剤組成物
US5019395A (en) * 1988-03-08 1991-05-28 Warner-Lambert Company Compositions with enhanced penetration
IE62871B1 (en) * 1988-03-08 1995-03-08 Warner Lambert Co Compositions with enhanced penetration
US4980175A (en) * 1989-01-03 1990-12-25 Leonard Chavkin Liquid orally administrable compositions based on edible oils
US4988679A (en) * 1989-01-03 1991-01-29 Leonard Chavkin Liquid sustained release composition
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5122384A (en) * 1989-05-05 1992-06-16 Kv Pharmaceutical Company Oral once-per-day organic nitrate formulation which does not induce tolerance
JPH0827003A (ja) * 1994-07-22 1996-01-30 Sekisui Chem Co Ltd 経皮吸収製剤
US6787342B2 (en) * 2000-02-16 2004-09-07 Merial Limited Paste formulations
TWI307634B (enExample) * 2001-03-30 2009-03-21 Shiseido Co Ltd
KR100598871B1 (ko) * 2001-09-10 2006-07-12 에프. 호프만-라 로슈 아게 유성 요변성 제제
US20040029959A1 (en) * 2002-08-08 2004-02-12 John Devane Isosorbide mononitrate compositions and methods of their use
US7459146B2 (en) * 2003-05-30 2008-12-02 3M Innovative Properties Company Stabilized aerosol dispersions
US7109247B2 (en) 2003-05-30 2006-09-19 3M Innovative Properties Company Stabilized particle dispersions containing nanoparticles
US20040242729A1 (en) * 2003-05-30 2004-12-02 3M Innovative Properties Company Stabilized particle dispersions containing surface-modified inorganic nanoparticles
DE102005061965A1 (de) * 2005-12-23 2007-07-05 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Oxidische Agglomeratpartikel, Verfahren zur Herstellung von Nanokompositen sowie deren Verwendung
JP5852732B2 (ja) * 2011-04-13 2016-02-03 イーエルシー マネージメント エルエルシー パーソナルケア組成物用コンディショニング剤
US9242930B2 (en) 2011-04-13 2016-01-26 Elc Management Llc Mild anionic surfactants suitable for personal care compositions
MX2014001557A (es) 2011-08-12 2014-03-31 Boehringer Ingelheim Vetmed Inhibidores de corrientes funny (if) para utilizar en un metodo de tratamiento y prevencion de la insuficiencia cardiaca en felinos.
CA2902911C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3028307A (en) * 1959-05-27 1962-04-03 Warner Lambert Pharmaceutical Pre-dried granulation and production of sublingual compressed organic nitrate tablets with selected solubilizing agents
NL110701C (enExample) * 1960-03-14
US3096242A (en) * 1960-05-20 1963-07-02 Atlas Chem Ind Vasodilator drug mixtures and excipient therefor
DE1642998B2 (de) * 1967-03-23 1973-05-17 Verfahren zur verhinderung der agglomeration feinteiliger, 1ulverfoermiger stoffe
GB1315197A (en) * 1970-07-13 1973-04-26 Explosives & Chem Prod Explosive gel compositions
US4112115A (en) * 1976-11-08 1978-09-05 Coghlan Charles C Therapy of leg muscle cramps
CA1163561A (en) * 1979-11-06 1984-03-13 Cyril Boroda Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
AU1873783A (en) * 1982-10-08 1984-04-12 Verex Laboratories Inc. Constant release formulation

Also Published As

Publication number Publication date
ES535914A0 (es) 1985-06-01
DE3333639A1 (de) 1985-03-28
DE3333639C2 (enExample) 1988-01-14
JPH0645537B2 (ja) 1994-06-15
DE3485638D1 (de) 1992-05-14
FI83838C (fi) 1991-09-10
EP0137978A3 (en) 1986-10-08
FI83838B (fi) 1991-05-31
US4611008A (en) 1986-09-09
JPS6067416A (ja) 1985-04-17
EP0137978B1 (de) 1992-04-08
ATE74518T1 (de) 1992-04-15
FI843615A0 (fi) 1984-09-14
FI843615L (fi) 1985-03-18
EP0137978A2 (de) 1985-04-24

Similar Documents

Publication Publication Date Title
ES8505541A1 (es) Procedimiento para producir una preparacion de gel o preparacion que contiene gel
AU3521389A (en) Bearings having beam mounted bearing pads and methods of making same
GR3004281T3 (enExample)
IT8324139A0 (it) Innesto vascolare e metodo per rifornire il sangue.
AU5688990A (en) Dynamic fixation of porcine aortic valves
AU4244885A (en) Triphenylmethyl derivatives of glycero-3-phosphocholine and glycero-3-phosphoethanolamine
AU6897687A (en) Method and additives for improving the quality and shelf life of stored blood
EP0328957A3 (en) Mixture of a thrombolytically acting and an antithrombolytically acting substance
EP0257003A3 (en) An enzyme preparation capable of degrading glycosaminoglycan, and a method for producing said preparation
EP0241314A3 (en) An accelerator of the activity of hydrolase
EP0646746A3 (en) Bearings comprising bearing segments mounted on beams and methods of making them.
ZA885625B (en) Therapeutic agents containing enantiomers of propafenone
AU92306S (en) Buddha figurine
AU5632590A (en) Method of inactivating lipase
IT8405111A1 (it) Procedimento per la lavorazione di perni di assali, alberi e simili.
SU1235053A1 (ru) Способ прокатки непрерывно отливаемой заготовки
SU1172397A1 (ru) Способ изготовления прецизионных резисторов
SU1212012A1 (ru) Производные 4,5-дигидропирроло[1,2,3-е,d]птеридина, обладающие противоопухолевой активностью, и способ их получения
AU100583S (en) Aquarium-birdcage combination
SU1208765A1 (ru) Способ получения производных феноксифенилмочевины
AU100024S (en) Musical instrument
SU1220227A1 (ru) Способ изготовления пористых заготовок из титановых сплавов
AU619442C (en) An accelerator of the activity of hydrolase
SU1270959A1 (ru) Способ отливки слоистых металлических заготовок
SU1051808A1 (ru) Способ полунепрерывного литья полых заготовок и установка для его осуществления

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519